Our Company
Xanamem^®
Clinical Development
Investor Centre
News
Contact Us

BACK TO NEWS

Actinogen • 05 Feb 2020

Bell Potter: “First Response in Cognition”

Enjoyed this read?

Stay up to date with our latest research.

Related articles

Awareness

International Clinical Trials Day

Actinogen • May 20, 2022

Corporate Presentations

Actinogen trial results & strategic update presentation

Actinogen • May 4, 2022

Media

Positive test results for Alzheimer’s drug Xanamem

Eminetra Australia • April 28, 2022

Our Company
Xanamem^®

Clinical Development

Investors
News
Contact Us

Copyright © 2022 Actinogen